Will Rosellini

Nexeon MedSystems, Inc. has commenced “regular way” trading on the OTC Market under the symbol “NXNN”. The company is finalising development of its deep brain stimulation system for the treatment of symptoms associated with Parkinson’s disease.

In 2013, president Obama launched the BRAIN Initiative as a large-scale effort to equip researchers with insights necessary for treating a wide variety of brain disorders like Alzheimer’s, schizophrenia, autism, epilepsy, and traumatic brain injury.

Nexeon MedSystems, a company that provides deep learning systems for implantable medical devices has licensed a portfolio of patents from Marathon Patent Group.